Investor Type | Firm |
Industries | BioTech • Life Science |
Investing | Germany |
Medicis Capital is a Munich-based venture capital firm with a strong emphasis on the healthcare sector. Established in 1994, Medicis actively supports mid-sized healthcare businesses with ambitious strategic growth objectives. Their expertise spans various subfields within healthcare, including Pharma (both prescription and non-prescription), Biotechnology, Medical Technology, Diagnostics, and Healthcare Services, along with other life science areas. The firm’s services are tailored to help companies in both growth stages and mature stages that face complex strategic challenges. They are particularly adept at addressing special situations that require creative problem-solving. For companies aiming for expansion or restructuring, Medicis provides comprehensive support in designing and implementing strategic growth plans. This might involve organic growth, portfolio development, creating a substantial international footprint in Western Europe, or inorganic strategies that include mergers and acquisitions. Furthermore, Medicis offers robust teams, led by experienced principals, to run or support companies through these transformative periods. In addition to their operational involvement, Medicis can set up whole subsidiaries in Germany and other principal EU geographies, thereby facilitating companies’ establishment and expansion across Europe. Medicis acts as an investor in special situations demanding active post-acquisition management and coaching, where they bring their expertise to ensure successful transitions. The firm distinguishes itself by serving as an integrative M&A advisor. They prepare, coach, and develop companies and their teams for transaction readiness, guiding them all the way through the deal-making process. With a legacy of over two decades, Medicis prides itself on its strategic and operational know-how that propels healthcare companies forward.